Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

N-acety-b-D-glucosaminidase: A potential biomarker for early detection of acute kidney injury in acute chest pain.

Kaufmann M, Schlossbauer M, Hubauer U, Stadler S, Fischer M, Wallner S, Hupf J, Zimmermann M, Orso E, Zeman F, Luchner A, Maier L, Jungbauer C.

Nephrology (Carlton). 2019 Sep 30. doi: 10.1111/nep.13664. [Epub ahead of print]

PMID:
31568610
2.

A novel muscle cramp scale (MCS) in amyotrophic lateral sclerosis (ALS).

Mitsumoto H, Chiuzan C, Gilmore M, Zhang Y, Ibagon C, McHale B, Hupf J, Oskarsson B.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):328-335. doi: 10.1080/21678421.2019.1603310. Epub 2019 Apr 22. Erratum in: Amyotroph Lateral Scler Frontotemporal Degener. 2019 Jun 11;:1.

PMID:
31007059
3.

The role of the tubular biomarkers NAG, kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin in patients with chest pain before contrast media exposition.

Schlossbauer MH, Hubauer U, Stadler S, Hupf J, Sag S, Birner C, Zimmermann M, Orso E, Fischer M, Luchner A, Maier LS, Jungbauer CG.

Biomark Med. 2019 Apr;13(5):379-392. doi: 10.2217/bmm-2018-0275. Epub 2019 Mar 28.

PMID:
30920848
4.

Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS Patients.

Woolley S, Goetz R, Factor-Litvak P, Murphy J, Hupf J, Lomen-Hoerth C, Andrews H, Heitzman D, Bedlack R, Katz J, Barohn R, Sorenson E, Oskarsson B, Filho AF, Kasarskis E, Mozaffar T, Nations S, Swenson A, Koczon-Jaremko A, Christodoulou G, Mitsumoto H.

Behav Neurol. 2018 Oct 31;2018:5969137. doi: 10.1155/2018/5969137. eCollection 2018.

5.

Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients.

Konrad C, Kawamata H, Bredvik KG, Arreguin AJ, Cajamarca SA, Hupf JC, Ravits JM, Miller TM, Maragakis NJ, Hales CM, Glass JD, Gross S, Mitsumoto H, Manfredi G.

Mol Neurodegener. 2017 Oct 24;12(1):76. doi: 10.1186/s13024-017-0217-5.

6.

Analytical and Clinical Validation of a Point-of-Care Cardiac Troponin T Test with an Improved Detection Limit.

Jungbauer C, Hupf J, Giannitsis E, Frick J, Slagman A, Ehret C, Herbert N, Jung C, Zerback R, Bertsch T, Christ M.

Clin Lab. 2017 Apr 1;63(4):633-645. doi: 10.7754/Clin.Lab.2016.160814.

PMID:
28397461
7.

Combined Inhibition of the Renin-Angiotensin System and Neprilysin Positively Influences Complex Mitochondrial Adaptations in Progressive Experimental Heart Failure.

Grois L, Hupf J, Reinders J, Schröder J, Dietl A, Schmid PM, Jungbauer C, Resch M, Maier LS, Luchner A, Birner C.

PLoS One. 2017 Jan 11;12(1):e0169743. doi: 10.1371/journal.pone.0169743. eCollection 2017.

8.

Association Between Dietary Intake and Function in Amyotrophic Lateral Sclerosis.

Nieves JW, Gennings C, Factor-Litvak P, Hupf J, Singleton J, Sharf V, Oskarsson B, Fernandes Filho JA, Sorenson EJ, D'Amico E, Goetz R, Mitsumoto H; Amyotrophic Lateral Sclerosis Multicenter Cohort Study of Oxidative Stress (ALS COSMOS) Study Group.

JAMA Neurol. 2016 Dec 1;73(12):1425-1432. doi: 10.1001/jamaneurol.2016.3401.

9.

Telephone based cognitive-behavioral screening for frontotemporal changes in patients with amyotrophic lateral sclerosis (ALS).

Christodoulou G, Gennings C, Hupf J, Factor-Litvak P, Murphy J, Goetz RR, Mitsumoto H.

Amyotroph Lateral Scler Frontotemporal Degener. 2016 Oct - Nov;17(7-8):482-488. Epub 2016 Apr 28.

10.

Phenotypic and molecular analyses of primary lateral sclerosis.

Mitsumoto H, Nagy PL, Gennings C, Murphy J, Andrews H, Goetz R, Floeter MK, Hupf J, Singleton J, Barohn RJ, Nations S, Shoesmith C, Kasarskis E, Factor-Litvak P.

Neurol Genet. 2015 Apr 14;1(1):e3. doi: 10.1212/01.NXG.0000464294.88607.dd. eCollection 2015 Jun.

11.

Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort.

Murphy J, Factor-Litvak P, Goetz R, Lomen-Hoerth C, Nagy PL, Hupf J, Singleton J, Woolley S, Andrews H, Heitzman D, Bedlack RS, Katz JS, Barohn RJ, Sorenson EJ, Oskarsson B, Fernandes Filho JA, Kasarskis EJ, Mozaffar T, Rollins YD, Nations SP, Swenson AJ, Koczon-Jaremko BA, Mitsumoto H; ALS COSMOS.

Neurology. 2016 Mar 1;86(9):813-20. doi: 10.1212/WNL.0000000000002305. Epub 2016 Jan 22.

12.

Non-invasive measurement of abnormal ventilatory mechanics in amyotrophic lateral sclerosis.

Layton AM, Moran SL, Roychoudhury A, Hupf J, Thomashow BM, Mitsumoto H.

Muscle Nerve. 2016 Aug;54(2):270-6. doi: 10.1002/mus.25043. Epub 2016 Jun 22.

PMID:
26800304
13.

Depression and wish to die in a multicenter cohort of ALS patients.

Rabkin JG, Goetz R, Factor-Litvak P, Hupf J, McElhiney M, Singleton J, Mitsumoto H; Als Cosmos Study Group.

Amyotroph Lateral Scler Frontotemporal Degener. 2015 Jun;16(3-4):265-73. doi: 10.3109/21678421.2014.980428. Epub 2014 Dec 8.

14.

Bioenergetic markers in skin fibroblasts of sporadic amyotrophic lateral sclerosis and progressive lateral sclerosis patients.

Kirk K, Gennings C, Hupf JC, Tadesse S, D'Aurelio M, Kawamata H, Valsecchi F, Mitsumoto H; ALS/PLS COSMOS Study Groups, Manfredi G.

Ann Neurol. 2014 Oct;76(4):620-4. doi: 10.1002/ana.24244. Epub 2014 Aug 21.

15.

Interatrial differences of basal molecular set-up and changes in tachycardia-induced heart failure-a proteomic profiling study.

Dietl A, Winkel I, Deutzmann R, Schröder J, Hupf J, Riegger G, Luchner A, Birner C.

Eur J Heart Fail. 2014 Aug;16(8):835-45. doi: 10.1002/ejhf.122. Epub 2014 Jul 12.

16.

Motor cortex glutathione deficit in ALS measured in vivo with the J-editing technique.

Weiduschat N, Mao X, Hupf J, Armstrong N, Kang G, Lange DJ, Mitsumoto H, Shungu DC.

Neurosci Lett. 2014 Jun 6;570:102-7. doi: 10.1016/j.neulet.2014.04.020. Epub 2014 Apr 24.

PMID:
24769125
17.

Japanese and American ALS patient preferences regarding TIV (tracheostomy with invasive ventilation): a cross-national survey.

Rabkin J, Ogino M, Goetz R, McElhiney M, Hupf J, Heitzman D, Heiman-Patterson T, Miller R, Katz J, Lomen-Hoerth C, Imai T, Atsuta N, Morita M, Tateishi T, Matsumura T, Mitsumoto H.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):185-91. doi: 10.3109/21678421.2014.896928. Epub 2014 Apr 10.

PMID:
24720451
18.

Experimental heart failure induces alterations of the lung proteome--insight into molecular mechanisms.

Birner C, Hierl S, Dietl A, Hupf J, Jungbauer C, Schmid PM, Rümmele P, Deutzmann R, Riegger G, Luchner A.

Cell Physiol Biochem. 2014;33(3):692-704. doi: 10.1159/000358645. Epub 2014 Mar 7.

19.

ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics.

Mitsumoto H, Factor-Litvak P, Andrews H, Goetz RR, Andrews L, Rabkin JG, McElhiney M, Nieves J, Santella RM, Murphy J, Hupf J, Singleton J, Merle D, Kilty M, Heitzman D, Bedlack RS, Miller RG, Katz JS, Forshew D, Barohn RJ, Sorenson EJ, Oskarsson B, Fernandes Filho JA, Kasarskis EJ, Lomen-Hoerth C, Mozaffar T, Rollins YD, Nations SP, Swenson AJ, Shefner JM, Andrews JA, Koczon-Jaremko BA; ALS COSMOS Study Group.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):192-203. doi: 10.3109/21678421.2013.864312. Epub 2014 Feb 24.

Supplemental Content

Support Center